Modulation of oral bioavailability of anticancer drugs: from mouse to man

This publication has 54 references indexed in Scilit:

• Oral chemotherapy: rationale and future directions.
  Journal of Clinical Oncology, 1998
• Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development
  British Journal of Cancer, 1997
• The bioavailability of oral GI147211 (GG211), a new topoisomerase I inhibitor
  British Journal of Cancer, 1997
• Suppression of intestinal and hepatic cytochrome P4503A in murineToxoplasma infection. Effects ofN-acetylcysteine andN^G-monomethyl-L-arginine on the hepatic suppression
  Xenobiotica, 1996
• BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
  Annual Review of Biochemistry, 1993
• Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
  Science, 1992
• Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities.
  Molecular and Cellular Biology, 1990
• The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues.
  Molecular and Cellular Biology, 1989
• Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.
  Proceedings of the National Academy of Sciences, 1989
• Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells
  Cell, 1986